Events

One of the largest Polish investments in Spain: Adamed presents its development plan for the Riells plant

9 October 2026

Nearly 70 representatives of central and regional government, local authorities, business organisations and the media attended Adamed’s press conference at the Riells plant in Spain on 8 October. During the event, the company presented its long-term development plan for the plant and its role in Adamed’s international manufacturing network, whose key pillar remains the company’s production facilities in Poland. 

Adamed’s total commitment connected with the acquisition and development of the plant will exceed EUR 100 million. The 2026–2034 plan covers investment in people, technologies and new products, as well as the modernisation of production, logistics and digital infrastructure. Adamed will also develop cooperation with the local community and environmental initiatives. The factory employs more than 260 people, can produce up to four billion tablets annually, and medicines manufactured there are currently supplied to 84 countries. 

“We have acquired a plant with more than 50 years of history, an experienced team and high quality standards. We want to preserve this industrial heritage while developing the factory through investment in people, technologies and new products. The plan we have prepared will enable us to realise Riells’ full potential,” said Małgorzata Adamkiewicz, MD, PhD, President of the Supervisory Board and co-owner of Adamed Pharma. 

Monika Krzepkowska, Chargé d’Affaires at the Embassy of the Republic of Poland in Spain, also emphasised the importance of the investment for the image of the Polish economy: “For Poland, this investment is particularly important. It demonstrates what Polish entrepreneurship can achieve through ambition, expertise and long-term commitment. It presents our country as it is today: modern, innovative and capable of building strong companies with an international reach.” 

Micaela Arias, Director of Invest in Spain at ICEX, which operates under Spain’s Ministry of Economy, Trade and Enterprise, described it as “one of the largest Polish investments in Spain”. 

Integrating the Riells plant into Adamed’s international manufacturing network will increase the company’s production capacity and strengthen the security and continuity of medicine supplies in Europe. 

Adamed has owned the Riells factory since 1 July 2026. It is the company’s first manufacturing plant in Western Europe. Adamed acquired the facility from Sanofi together with its experienced team, production base and existing customers.